PPAR-gamma agonist, ciglitazone, increases pigmentation and migration of human melanocytes

Experimental Dermatology

Volumn 16, Issue 2, 2007, Pages 118-123

  Lee, Joong Sun ^a   Choi, You Mi ^a   Kang, Hee Young ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Ciglitazone; Melanocyte; Migration; Peroxisome proliferator activated receptor ; Pigmentation

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CIGLITAZONE; MELANIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; TROGLITAZONE;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOCYTE; PROTEIN EXPRESSION; SKIN CELL; SKIN CULTURE; SKIN PIGMENTATION;

CELL MOVEMENT; GENE EXPRESSION; HUMANS; MELANINS; MELANOCYTES; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; ORGAN CULTURE TECHNIQUES; PIGMENTATION; PPAR GAMMA; SKIN PHYSIOLOGY; THIAZOLIDINEDIONES;

EID: 33845966377     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2006.00521.x     Document Type: Article

References (28)

1. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990: 347: 645-650.
2. Schoonjans K, Martin G, Staels B, Auwerx J. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 1997: 8: 159-166.
3. Lemberger T, Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 1996: 12: 335-363.
4. Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, Michel S. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 1998: 111: 1116-1121.
5. Kang H Y, Chung E, Lee M, Cho Y. Kang W H. Expression and function of peroxisome proliferator-activated receptors in human melanocytes. Br J Dermatol 2004: 150: 462-468.
6. Chen W, Yang C C, Sheu H M, Seltmann H, Zouboulis C C. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 2003: 121: 441-447.
7. Ghosh A K, Bhattacharyya S, Lakos G, Chen S J, Mori Y, Varga J. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma. Arthritis Rheum 2004: 50: 1305-1318.
8. Fajas L, Debril M B, Auwerx J. Peroxisome proliferator-activated receptor-gamma: From adipogenesis to carcinogenesis. J Mol Endocrinol 2001: 27: 1-9.
9. Kuenzli S, Saurat J H. Peroxisome proliferator-activated receptors in cutaneous biology. Br J Dermatol 2003: 149: 229-236.
10. Goetze S, Eilers F, Bungenstock A et al. PPAR activators inhibit endothelial cell migration by targeting Akt. Biochem Biophys Res Commun 2002: 293: 1431-1437.
11. Tanaka T, Fukunaga Y, Itoh H et al. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration. Eur J Pharmacol 2005: 508: 255-265.
12. Ellis C N, Varani J, Fisher G J et al. Troglitazone improves psoriasis and normalizes models of proliferative skin disease: Ligands for peroxisome proliferator-activated receptor gamma inhibit keratinocyte proliferation. Arch Dermatol 2000: 136: 609-616.
13. Demerjian M, Man M Q, Choi E H et al. Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model. Exp Dermatol 2006: 15: 154-160.
14. Mossner R, Schulz U, Kruger U et al. Agonists of peroxisome proliferator activated receptor gamma inhibit cell growth in malignant melanoma. J Invest Dermatol 2002: 119: 576-582.
15. Placha W, Gil D, Dembinska-Kiec A, Laidler P. The effect of PPARgamma ligands on the proliferation and apoptosis of human melanoma cells. Melanoma Res 2003: 13: 447-456.
16. Watabe H, Soma Y, Ito M, Kawa Y, Mizoguchi M. All-trans retinoic acid induces differentiation and apoptosis of murine melanocyte precursors with induction of the microphthalmia-associated transcription factor. J Invest Dermatol 2002: 118: 35-42.
17. Sauer B, Ruwisch L, Kleuser B. Antiapoptotic action of 1alpha,25-dihydroxyvitamin D3 in primary human melanocytes. Melanoma Res 2003: 13: 339-347.
18. Watabe H, Soma Y, Kawa Y et al. Differentiation of murine melanocyte precursors induced by 1,25-dihydroxyvitamin D3 is associated with the stimulation of endothelin B receptor expression. J Invest Dermatol 2002: 119: 583-589.
19. Eisinger M, Marko O. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci U S A 1982: 79: 2018-2022.
20. Kivinen P K, Hyttinen M, Harvima R J, Naukkarinen A, Horsmanheimo M, Harvima I T. Quantitative digital image analysis applied to demonstrate the stratified distribution of involucrin in organ cultured human skin. Arch Dermatol Res 1999: 291: 217-223.
21. Tsuboi T, Kondoh H, Hiratsuka J et al. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma. Pigment Cell Res 1998: 11: 275-282.
22. Tomita Y, Maeda K, Tagami H. Melanocyte-stimulating properties of arachidonic acid metabolites: Possible role in postinflammatory pigmentation. Pigment Cell Res 1992: 5: 357-361.
23. Gordon-Thomson C, Jones J, Mason R S et al. ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells. Melanoma Res 2005: 15: 21-28.
24. Wiechers J W, Rawlings A V, Garcia C et al. A new mechanism of action for skin whitening agents: Binding to the peroxisome proliferator-activated receptor. Int J Cosmet Sci 2005: 27: 123-132.
25. Hedley S J, Gawkrodger D J, Weetman A P et al. alpha-Melanocyte stimulating hormone inhibits tumour necrosis factor-alpha stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines. Br J Dermatol 1998: 138: 536-543.
26. Simon H G, Risse B, Jost M, Oppenheimer S, Kari C, Rodeck U. Identification of differentially expressed messenger RNAs in human melanocytes and melanoma cells. Cancer Res 1996: 56: 3112-3117.
27. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998: 197: 167-170.
28. Ameen M, Exarchou V, Chu A C. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol 2001: 145: 476-479.